This company listing is no longer active
QTNT.Q Stock Overview
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Quotient Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.039 |
| 52 Week High | US$21.13 |
| 52 Week Low | US$0.032 |
| Beta | 2.37 |
| 1 Month Change | 10.64% |
| 3 Month Change | -28.77% |
| 1 Year Change | -99.72% |
| 3 Year Change | -99.99% |
| 5 Year Change | -99.99% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Quotient expands MosaiQ Innovator's Circle
Aug 24Quotient teams up with InfYnity Biomarkers to advance infectious disease testing
Jul 12Analysts Just Shaved Their Quotient Limited (NASDAQ:QTNT) Forecasts Dramatically
Feb 10
Quotient beats on revenue; issues guidance
Jun 01Here's Why Quotient (NASDAQ:QTNT) Can Afford Some Debt
Apr 12A Look At Quotient's (NASDAQ:QTNT) Share Price Returns
Mar 08Quotient EPS beats by $0.01, beats on revenue
Feb 01Read This Before Selling Quotient Limited (NASDAQ:QTNT) Shares
Feb 01Is Quotient (NASDAQ:QTNT) A Risky Investment?
Jan 04
Quotient operations chief resigns
Dec 22Quotient drops ~7% as FDA requires additional data for regulatory clearance
Dec 10Quotient (NASDAQ:QTNT) Shareholders Have Enjoyed A 58% Share Price Gain
Dec 07Quotient's Disruptive MosaiQ Platform And Its Upcoming Approval
Nov 17Quotient EPS beats by $0.16, beats on revenue
Nov 02Shareholder Returns
| QTNT.Q | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 14.7% | -4.1% | -3.7% |
| 1Y | -99.7% | -2.2% | 20.5% |
Return vs Industry: QTNT.Q underperformed the US Medical Equipment industry which returned 12.7% over the past year.
Return vs Market: QTNT.Q underperformed the US Market which returned 14% over the past year.
Price Volatility
| QTNT.Q volatility | |
|---|---|
| QTNT.Q Average Weekly Movement | 68.1% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: QTNT.Q's share price has been volatile over the past 3 months.
Volatility Over Time: QTNT.Q's weekly volatility has increased from 46% to 68% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 432 | Manuel Mendez | www.quotientbd.com |
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping.
Quotient Limited Fundamentals Summary
| QTNT.Q fundamental statistics | |
|---|---|
| Market cap | US$821.15k |
| Earnings (TTM) | -US$124.03m |
| Revenue (TTM) | US$37.41m |
0.0x
P/S Ratio0.0x
P/E RatioIs QTNT.Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QTNT.Q income statement (TTM) | |
|---|---|
| Revenue | US$37.41m |
| Cost of Revenue | US$37.13m |
| Gross Profit | US$279.00k |
| Other Expenses | US$124.31m |
| Earnings | -US$124.03m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -5.89 |
| Gross Margin | 0.75% |
| Net Profit Margin | -331.54% |
| Debt/Equity Ratio | -126.2% |
How did QTNT.Q perform over the long term?
See historical performance and comparison